Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Rubric Capital Management LP reported a 6.75% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Rubric Capital Management LP reported a 6.75% stake in Arcutis Biotherapeutics, Inc., 8,271,577 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 6.75%
- Shares
- 8,271,577
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rubric Capital Management LP | 6.75% | 8,271,577 |
| David Rosen | 6.75% | 8,271,577 |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Rubric Capital Management LP
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026